Bluesight's KLAS Streak Signals Unwavering Trust in Healthcare Tech

📊 Key Data
  • 5th win for ControlCheck in Drug Diversion Monitoring
  • 6th win for PrivacyPro in Patient Privacy Monitoring
  • 3,000+ hospitals supported by Bluesight
🎯 Expert Consensus

Experts would likely conclude that Bluesight's repeated KLAS wins demonstrate sustained customer trust and proven effectiveness in addressing critical healthcare challenges like drug diversion and patient privacy.

2 months ago
Bluesight's KLAS Streak Signals Unwavering Trust in Healthcare Tech

Bluesight's KLAS Dominance Signals Unwavering Trust in Healthcare Tech

ARLINGTON, Va. – February 04, 2026 – Health system intelligence leader Bluesight has once again solidified its market leadership, securing two coveted Best in KLAS awards for its flagship solutions, ControlCheck and PrivacyPro. The recognition, announced in the 2026 Best in KLAS Software & Services report, marks the fifth win for ControlCheck in Drug Diversion Monitoring and a remarkable sixth win for PrivacyPro in Patient Privacy Monitoring.

This consistent, multi-year recognition underscores the deep trust healthcare organizations place in Bluesight's platform to navigate some of the most critical and complex challenges in modern hospital operations: protecting patient data and preventing the diversion of controlled substances.

The Gold Standard of Customer Validation

In the crowded and often confusing healthcare IT marketplace, the Best in KLAS designation serves as a crucial, independent benchmark. Unlike many industry awards, KLAS Research’s accolades are not determined by a panel of judges or vendor applications. Instead, they are derived exclusively from thousands of in-depth, candid interviews with the healthcare professionals who use these technologies daily.

This customer-driven methodology is what gives the award its weight. A Best in KLAS win signifies that a product not only delivers on its promises but also provides exceptional value, backed by reliable support and a true partnership ethos. For a company to achieve this honor multiple years in a row, as Bluesight has, it indicates a sustained commitment to customer success and product excellence that resonates deeply with its user base. This streak of success validates the real-world impact and reliability of the company's solutions in high-stakes environments. The recognition is a direct reflection of performance, usability, and the vendor's ability to help healthcare organizations achieve tangible outcomes.

"Earning Best in KLAS recognition year after year reflects the trust our customers place in Bluesight," said Kevin MacDonald, CEO and Co-Founder of Bluesight, in a statement. "These awards validate our commitment to our customers, innovating with purpose, and delivering solutions that help health systems reduce risk, improve safety, and operate more efficiently."

Proactively Securing Patients and Data

Bluesight’s award-winning solutions tackle two of the most significant risk areas in healthcare with a proactive, technology-forward approach that moves beyond simple compliance checklists.

PrivacyPro, now a six-time Best in KLAS winner, addresses the ever-present threat of patient privacy violations. In an era of digital health records, the potential for unauthorized access to sensitive patient information—whether malicious or accidental—is a major concern for compliance officers. PrivacyPro leverages advanced analytics and machine learning to sift through vast amounts of data, proactively detecting suspicious activity and potential HIPAA breaches. This allows compliance teams to shift from time-consuming manual audits to focusing their attention on the highest-risk behaviors, enabling faster investigation and mitigation. The solution's consistent high performance was further highlighted in late 2025 when KLAS named it a "Consistent High Performer" for maintaining an overall score above 90 for three consecutive years.

On the pharmaceutical front, ControlCheck provides an end-to-end, closed-loop system for monitoring and preventing drug diversion. The theft of controlled substances from hospitals is a pervasive problem that jeopardizes patient safety, puts staff at risk, and creates significant legal and financial liability. ControlCheck helps health systems identify and prevent this diversion across all hospital workflows—from pharmacy to nursing stations and procedural areas. By providing a comprehensive view of medication pathways, the solution empowers hospitals to proactively identify anomalies that could indicate diversion, protecting both patients and the integrity of their care delivery.

From Risk Mitigation to Operational Excellence

While the primary function of ControlCheck and PrivacyPro is to mitigate risk, their impact extends far beyond compliance, contributing directly to a hospital's operational and financial health. The cost of a single patient data breach or a significant drug diversion event can be astronomical, encompassing regulatory fines, legal fees, reputational damage, and the loss of patient trust.

By implementing these sophisticated monitoring tools, healthcare organizations are making a strategic investment in their own stability. The efficiency gained by automating privacy audits with PrivacyPro frees up valuable staff time for higher-value tasks. Similarly, the robust oversight provided by ControlCheck not only secures the medication supply chain but also optimizes inventory management and reduces waste. These operational gains translate into measurable financial impact, helping health systems protect their bottom line in an industry facing constant margin pressure.

This comprehensive approach is central to Bluesight's mission. The company, which supports over 3,000 hospitals, aims to provide an intelligence platform that ensures patient protection while optimizing every dollar spent. The consistent praise from customers via the KLAS reports confirms the value of this integrated strategy.

"What makes these recognitions especially meaningful is that they're driven entirely by customer feedback," MacDonald added. "Our teams remain focused on delivering technology that works in the real world while continually upholding our core value of honoring the customer."

Looking ahead, Bluesight is focused on deepening the integration between its products to create a more unified intelligence platform. The company is also committed to the responsible use of artificial intelligence and is actively seeking strategic partnerships to make its solutions more accessible and impactful for health systems nationwide, ensuring they remain at the forefront of protecting patients and powering efficient hospital operations.

Event: Industry Conference
Sector: AI & Machine Learning Health IT Software & SaaS
Theme: Data Breaches Privacy Engineering Healthcare Regulation (HIPAA) Machine Learning Telehealth & Digital Health Value-Based Care Artificial Intelligence
Product: Analytics Tools
UAID: 14194